UTime Limited (NASDAQ:WTO) shares rose 31.7% on Wednesday after the mobile technology company announced a nearly US$ 10 million acquisition deal with Tumu Vertex LLC, based in Denver, for smart health devices.

The deal involves an initial order of 50,000 premium smart health devices, including blood pressure watches and smart rings. According to the company, the first batch of products will begin to be delivered in the first quarter of 2026, with all products undergoing joint quality control procedures.

"This cooperation represents a significant strategic advancement for us in the North American market," declared UTime's CEO during the signing ceremony. The company views this agreement as an opportunity to accelerate the development of next-generation health monitoring technologies.

Monil Hossain, founder and CEO of Tumu Vertex LLC, said: "The technological innovation and product quality of UTime have deeply impressed us. These devices will be used for our smart health services platform in the United States, providing users with 24/7 health monitoring solutions."

The order includes 25,000 units of UT-168 BT Blood Pressure Watches and 25,000 Smart Rings UR08 ECG, as well as 25,000 units of UT-368 4G Blood Pressure Watches and 25,000 Smart Rings UR01.

The agreement follows internationally recognized trade frameworks, covering FOB Hong Kong delivery, phased payments, and standardized quality assurance systems, according to UTime.